The war on ‘prediabetes’ could be a boon for pharma—but is it good medicine?
A third of Americans are considered prediabetic—but many may be better off without treatment
Science Fund for Investigative Reporting
-
-
Private research funders court controversy with billions in secretive investments
Critics say offshore investing by high-minded foundations shores up a nefarious system -
Meta-analyses were supposed to end scientific debates. Often, they only cause more controversy
Compiling the evidence from dozens of studies doesn't always bring clarity -
Hidden conflicts? Pharma payments to FDA advisers after drug approvals spark ethical concerns
Science investigation of journal disclosures and pharmaceutical funding records shows potential influence on physician gatekeepers -
FDA’s revolving door: Companies often hire agency staffers who managed their successful drug reviews
Job changes raise conflict of interest questions -
Famed cancer biologist allegedly sexually harassed women for decades
As Inder Verma soared at Salk Institute, women say a parallel tale of unwelcome advances and comments unfolded -
Disturbing allegations of sexual harassment in Antarctica leveled at noted scientist
Two women allege their team leader bullied them at remote research sites years ago. Now they are taking action
